Quest Diagnostics Reports Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Quest Diagnostics (DGX) Tops Q2 EPS by 2c; Maintains Guidance
July 23, 2015 7:02 AM EDTQuest Diagnostics (NYSE: DGX) reported Q2 EPS of $1.25, $0.02 better than the analyst estimate of $1.23. Revenue for the quarter came in at $1.93 billion versus the consensus estimate of $1.93 billion.
Quest Diagnostics maintained FY2015 EPS of $4.70-$4.85, versus the consensus of $4.73.
"In the... More



